HeadlineShine

Alembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%

NDTV ProfitAlembic Pharma's Stock Hits Upper Circuit After Q2 Profit Zooms Over 81%
Image: NDTV Profit

The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.

Summary from NDTV Profit

Read the full story on NDTV Profit
React

Related stories

More business

See all →

Top stories in India

See all →